| Website | pharmalink.se |
| Category | BioTech |
| Phone | +46 (0)8 411 3005 |
| johan.haggblad@ph... | |
| Employees |
| TOTAL | $5.09M |
| FUNDING TOTAL | $5.09M |
| Venture Round, 1/12 Industrifonden | kr35M |
Pharmalink AB, a specialty pharmaceutical company that develops pharmaceutical products in fields of unmet medical need. Its products include Nefecon, a treatment for IgA nephropathy and Busulipo, an alternative for myeloablation prior to bone marrow transplantation. The company was founded in 1991 and is headquartered in Stockholm, Sweden.
